|
Volumn 16, Issue 3, 2010, Pages 229-232
|
Effectiveness of 23-valent penumococcal polysaccharide and split-virus influenza vaccines to prevent respiratory diseases for elderly people
|
Author keywords
[No Author keywords available]
|
Indexed keywords
23 VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE;
23-VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE;
INFLUENZA VACCINE;
PNEUMOCOCCUS VACCINE;
AGED;
AGING;
ARTICLE;
CASE CONTROL STUDY;
CHINA;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
ECONOMICS;
FEMALE;
FOLLOW UP;
HOSPITALIZATION;
HUMAN;
IMMUNOLOGY;
INFLUENZA;
MALE;
MIDDLE AGED;
RESPIRATORY TRACT INFECTION;
VACCINATION;
VIROLOGY;
AGED;
AGED, 80 AND OVER;
AGING;
CASE-CONTROL STUDIES;
CHINA;
COST-BENEFIT ANALYSIS;
FEMALE;
FOLLOW-UP STUDIES;
HOSPITALIZATION;
HUMANS;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
MALE;
MIDDLE AGED;
PNEUMOCOCCAL VACCINES;
RESPIRATORY TRACT INFECTIONS;
VACCINATION;
|
EID: 77957362573
PISSN: 1006916X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|